Ivabradine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ivabradine and local guidelines before prescribing.
If channel inhibitor
Mechanism
If channel inhibitor in the sinus node.
Uses
Heart failure with reduced EF in sinus rhythm (HR 75 or above), chronic angina.
Dosing
- Ivabradine | 5 mg twice daily (2.5 mg if ≥75), max 7.5 mg twice daily. Sinus rhythm, HR ≥70.
Cardiology: Ischaemic Heart Disease (ACS) - Ivabradine | Usually 5 mg twice daily initially; up to 7.5 mg twice daily when indicated.
Cardiology: Heart Failure - Ivabradine | HFrEF in sinus rhythm with heart rate ≥75/min (NICE TA267): 5 mg twice daily, up to 7.5 mg twice daily (2.5 mg twice daily in older patients).
Cardiology: Cardiomyopathies
Side effects
Visual phosphenes, bradycardia, AF, headache.
Interactions
Verapamil and diltiazem; strong CYP3A4 inhibitors.
Contraindications and cautions
Heart rate below 70, sick sinus syndrome
Monitoring
Heart rate, ECG
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in severe hepatic impairment
Overdose and reversal
Supportive; atropine
Special advice
ECG for AF during treatment; avoid with beta-blocker caveats per heart rate target.
More from the textbook: uses, cautions and other points
- Ivabradine - blocks the If (funny) current in the SA node → slower heart rate without lowering BP; only works in sinus rhythm ; side effects - phosphenes (flashing lights), bradycardia; also used in HFrEF (heart rate 75 or more).
Cardiology: Anatomy Physiology and Pharmacology - No stable resting potential - phase 4 slowly depolarises through the " funny " (If) sodium current (blocked by ivabradine ) and T-type calcium channels.
Cardiology: Anatomy Physiology and Pharmacology - Myocardial oxygen demand is set by heart rate, contractility and wall stress (preload and afterload) - antianginal drugs work by lowering these (beta-blockers, nitrates, calcium channel blockers, ivabradine) or improving flow.
Cardiology: Anatomy Physiology and Pharmacology - Others | Adenosine , digoxin , magnesium , atropine, ivabradine | Adenosine - SVT; digoxin - rate control; magnesium - torsades; atropine - bradycardia
Cardiology: Anatomy Physiology and Pharmacology - Ivabradine | If channel blocker; sinus rhythm only; phosphenes.
Cardiology: Anatomy Physiology and Pharmacology - Current blocked by ivabradine | The funny current (If) in the SA node
Cardiology: Anatomy Physiology and Pharmacology - Flashing lights in bright light on a new angina drug | Ivabradine (phosphenes)
Cardiology: Anatomy Physiology and Pharmacology - Pacemaker cells: If current (ivabradine), calcium upstroke (verapamil, diltiazem).
Cardiology: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (8 mentions)
- Cardiology Investigations (1 mention)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiomyopathies (3 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Integrated cardiology chapter (6 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)